BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2018;38:198-209. [PMID: 28865179 DOI: 10.1111/liv.13584] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Lucena MI, Sanabria J, García-cortes M, Stephens C, Andrade RJ. Drug-induced liver injury in older people. The Lancet Gastroenterology & Hepatology 2020;5:862-74. [DOI: 10.1016/s2468-1253(20)30006-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
3 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
4 Andrade RJ, Robles‐díaz M. Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice. Liver Int 2019;40:6-17. [DOI: 10.1111/liv.14271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
5 Covelli C, Sacchi D, Sarcognato S, Cazzagon N, Grillo F, Baciorri F, Fanni D, Cacciatore M, Maffeis V, Guido M. Pathology of autoimmune hepatitis. Pathologica 2021;113:185-93. [PMID: 34294936 DOI: 10.32074/1591-951X-241] [Reference Citation Analysis]
6 Wang L, Wang Y, Wee A, Soon G, Gouw ASH, Yang R, Tian Q, Liu L, Ma H, Zhao X. Clinicopathological features of Bu Gu Zhi-induced liver injury, a long-term follow-up cohort study.Liver Int. 2020;40:571-580. [PMID: 31758650 DOI: 10.1111/liv.14306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu Y, Li P, Wang F, Liu L, Zhang Y, Liu Y, Shi R. Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury. Medicine (Baltimore) 2020;99:e22259. [PMID: 33031266 DOI: 10.1097/MD.0000000000022259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wang H, Liu C, He Z, Li P, Zhang W, Zhang W, Tang B. Dual-Colored Fluorescence Imaging of Mitochondrial HNO and Golgi-HNO in Mice with DILI. Anal Chem 2021;93:6551-8. [PMID: 33848128 DOI: 10.1021/acs.analchem.1c00742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tian QJ, Zhao XY, Wang Y, Wee A, Soon GST, Gouw ASH, Li M, Yang RY, Wang L, Wang QY, Duan WJ, Wang Y, Wang XM, Kong YY, Ou XJ, You H, Jia JD. Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury. Mod Pathol 2019;32:1795-805. [PMID: 31300804 DOI: 10.1038/s41379-019-0314-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
12 Hernandez N, Pontet Y, Bessone F. Translating new knowledge on drug-induced liver injury into clinical practice. Frontline Gastroenterol 2020;11:303-10. [PMID: 32587673 DOI: 10.1136/flgastro-2018-101120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l. Drug-induced liver injury: a safety review. Expert Opin Drug Saf 2018;17:795-804. [PMID: 30059261 DOI: 10.1080/14740338.2018.1505861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
14 Wang Q, Huang A, Wang JB, Zou Z. Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Front Pharmacol 2021;12:627133. [PMID: 33762948 DOI: 10.3389/fphar.2021.627133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]